CME Group Inc. (NASDAQ:CME) Shares Bought by Twin Capital Management Inc.

Twin Capital Management Inc. raised its position in CME Group Inc. (NASDAQ:CME) by 1.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 13,634 shares of the financial services provider’s stock after buying an additional 215 shares during the period. Twin Capital Management Inc.’s holdings in CME Group were worth $3,166,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. SJS Investment Consulting Inc. lifted its stake in CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 97 shares in the last quarter. Dunhill Financial LLC lifted its holdings in CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after buying an additional 81 shares during the last quarter. New Age Alpha Advisors LLC boosted its holdings in CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 43 shares in the last quarter. Financial Life Planners acquired a new stake in CME Group during the 4th quarter worth $32,000. Finally, Knuff & Co LLC purchased a new stake in shares of CME Group in the 4th quarter valued at about $33,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Howard J. Siegel sold 10,000 shares of CME Group stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the transaction, the director now directly owns 21,873 shares of the company’s stock, valued at $5,686,980. The trade was a 31.37 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Julie Winkler sold 11,592 shares of the company’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the transaction, the insider now directly owns 21,885 shares in the company, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 27,076 shares of company stock valued at $6,871,496 over the last quarter. Corporate insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Erste Group Bank upgraded CME Group to a “strong-buy” rating in a research report on Monday, March 17th. Raymond James raised CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 target price for the company in a research note on Monday, March 10th. Barclays raised their target price on CME Group from $257.00 to $263.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Oppenheimer upped their price target on shares of CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a report on Thursday, February 13th. Finally, Morgan Stanley raised their price objective on shares of CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 19th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $241.53.

CME Group Trading Down 5.2 %

NASDAQ:CME opened at $254.46 on Monday. The stock has a market cap of $91.70 billion, a PE ratio of 26.31, a price-to-earnings-growth ratio of 6.76 and a beta of 0.53. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The stock’s 50-day moving average is $252.60 and its two-hundred day moving average is $237.46. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $273.42.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. As a group, equities research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th were issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.96%. The ex-dividend date was Friday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio (DPR) is presently 51.71%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.